TD SYNNEX Corporation SNX
228.15 USD +5.93 (+2.67%)
Nov 3, 2026, 3:59 PM EST
223.42 Day range 230.60
142.22 52-week range 298.77
- YTD
- +51.86%
- 1 year
- +48.80%
Analyst view
Consensus: buy
Buy
Price target (mean) 339.64 +48.9% upside
Now 228.15
- Target (low)
- 287.00
- Target (mean)
- 339.64
- Target (high)
- 379.00
Ratings (0m) 11 10 buy · 1 hold · 0 sell
- Strong buy4
- Buy6
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 11
- 1 month ago 11
- 2 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 5.99 | 5.89 – 6.18 | 3.83 | +56.3% | 22.24B | +28.0% | 11 |
| Next quarter | 5.39 | 4.53 – 6.46 | 4.73 | +13.9% | 20.45B | +19.1% | 9 |
| Current year | 21.24 | 21.15 – 21.42 | 13.19 | +61.0% | 80.53B | +28.8% | 11 |
| Next year | 24.63 | 23.01 – 28.70 | 21.24 | +15.9% | 89.16B | +10.7% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 25, 2026 | UBS | Maintained | Buy | Buy |
| Sep 25, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Sep 15, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Sep 8, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 2, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jun 26, 2026 | UBS | Maintained | Buy | Buy |
| Jun 26, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Jun 26, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jun 23, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jun 16, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Jun 12, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Jun 12, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Jun 10, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jun 9, 2026 | UBS | Maintained | Buy | Buy |
| May 29, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| May 27, 2026 | JP Morgan | Upgrade | Neutral | Overweight |
| May 5, 2026 | UBS | Maintained | Buy | Buy |
| Apr 30, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Apr 22, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Apr 16, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Apr 2, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Apr 1, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Apr 1, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Apr 1, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Apr 1, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Mar 27, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Mar 20, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jan 9, 2026 | UBS | Maintained | Buy | Buy |
| Jan 9, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jan 9, 2026 | Barrington Research | Maintained | Outperform | Outperform |